We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FWONA:NASDAQLiberty Media Corporation - Series A Liberty Formula One Analysis

Data as of 2026-09-27 - not real-time

$86.46

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind Formula One Group is neutral at $86.46, with no clear ordering between short and long averages. Across the trailing 30 sessions it lost 8.7%. Momentum indicators put RSI at 41.5 (neutral) with MACD reading bearish. The recent range runs from support at $85.13 up to resistance at $94.56.
On valuation the read is fair — earnings multiple of 106.7 versus a 15.6 sector average, above the peer group. Consensus targets land 28.4% above where the shares trade now. Revenue is growing at 18.3% on a 5.5% profit margin.
Risk comes out at 4 of a possible 10, a moderate reading. With 30-day volatility of 22.4%, a beta of 0.27 and a maximum drawdown of 25.0%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to hold, carrying 4/10 conviction.

Top Market Events

Liberty Media stock linked to its Formula One Group tracking shares closed at USD 85.Formula One Group stock traded at USD 86.Seeking Alpha16dFormula One Group: The Calendar Is Hiding The CompoundingFormula One Group offers compelling upside...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Trading above the 200-day average of 84.62
  • MACD momentum is negative
  • 30-day price change of -8.7%

Medium Term

1–3 years
Neutral
Model confidence: 4/10

Key Factors

  • P/E of 106.7 versus sector average of 15.6
  • Trading above the 200-day average of 84.62
  • Analyst targets imply +28.4% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • P/E of 106.7 versus sector average of 15.6
  • Analyst targets imply +28.4% versus the current price
  • Revenue growth of +18.3%

Key Metrics & Analysis

Financial Health

Revenue Growth18.30%
Profit Margin5.52%
P/E Ratio106.7
ROE2.73%
ROA2.22%
Debt/Equity59.88
P/B Ratio2.7
Op. Cash Flow$793.0M
Free Cash Flow$654.2M
Industry P/E15.6

Technical Analysis

TrendNeutral
RSI41.5
Support$85.13
Resistance$94.56
MA 20$88.01
MA 50$90.86
MA 200$84.62
MACDBearish
VolumeIncreasing
Fear & Greed Index94.88

Valuation

Fair Value$50.48
Target Price$111.00
Upside/Downside28.38%
GradeFair
TypeGrowth

Risk Assessment

Beta0.27
Volatility22.41%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.